Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria J Matos

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Structural Insight of New Butyrylcholinesterase Inhibitors Based on Benzylbenzofuran ScaffoldGiovanna L Delogu, Antonella Fais, Francesca Pintus, et al.
Bioorganic & Medicinal Chemistry|October 2, 2020
Sequential dual site-selective protein labelling enabled by lysine modificationMaria J Matos, Libby Brown, Barbara Bernardim, et al.
Chemmedchem|January 31, 2012
8-Substituted 3-arylcoumarins as potent and selective MAO-B inhibitors: synthesis, pharmacological evaluation, and docking studiesDolores Viña, Maria J Matos, Giulio Ferino, et al.
Molecules (Basel, Switzerland)|February 19, 2015
Study of coumarin-resveratrol hybrids as potent antioxidant compoundsMaria J Matos, Francisco Mura, Saleta Vazquez-Rodriguez, et al.
Bioorganic Chemistry|February 11, 2021
Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitorsMarco Mellado, César González, Jaime Mella, et al.
Bioorganic Chemistry|December 12, 2018
Synthesis, molecular docking and cholinesterase inhibitory activity of hydroxylated 2-phenylbenzofuran derivativesAntonella Fais, Amit Kumar, Rosaria Medda, et al.
Molecules (Basel, Switzerland)|January 26, 2013
Synthesis and structure-activity relationships of novel amino/nitro substituted 3-arylcoumarins as antibacterial agentsMaria J Matos, Saleta Vazquez-Rodriguez, Lourdes Santana, et al.
International Journal of Biological Macromolecules|June 24, 2020
Looking for new xanthine oxidase inhibitors: 3-Phenylcoumarins versus 2-phenylbenzofuransBenedetta Era, Giovanna L Delogu, Francesca Pintus, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2016
2-Phenylbenzofuran derivatives as butyrylcholinesterase inhibitors: Synthesis, biological activity and molecular modelingGiovanna L Delogu, Maria J Matos, Maura Fanti, et al.
Journal of Biomolecular Structure & Dynamics|January 31, 2023
In silico approaches to develop new phenyl-pyrimidines as glycogen synthase kinase 3 (GSK-3) inhibitors with halogen-bonding capabilities: 3D-QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studiesDavid Cabezas, Guido Mellado, Nicolás Espinoza, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Structural Insight of New Butyrylcholinesterase Inhibitors Based on Benzylbenzofuran ScaffoldGiovanna L Delogu, Antonella Fais, Francesca Pintus, et al.
Bioorganic & Medicinal Chemistry|October 2, 2020
Sequential dual site-selective protein labelling enabled by lysine modificationMaria J Matos, Libby Brown, Barbara Bernardim, et al.
Chemmedchem|January 31, 2012
8-Substituted 3-arylcoumarins as potent and selective MAO-B inhibitors: synthesis, pharmacological evaluation, and docking studiesDolores Viña, Maria J Matos, Giulio Ferino, et al.
Molecules (Basel, Switzerland)|February 19, 2015
Study of coumarin-resveratrol hybrids as potent antioxidant compoundsMaria J Matos, Francisco Mura, Saleta Vazquez-Rodriguez, et al.
Bioorganic Chemistry|February 11, 2021
Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitorsMarco Mellado, César González, Jaime Mella, et al.
Bioorganic Chemistry|December 12, 2018
Synthesis, molecular docking and cholinesterase inhibitory activity of hydroxylated 2-phenylbenzofuran derivativesAntonella Fais, Amit Kumar, Rosaria Medda, et al.
Molecules (Basel, Switzerland)|January 26, 2013
Synthesis and structure-activity relationships of novel amino/nitro substituted 3-arylcoumarins as antibacterial agentsMaria J Matos, Saleta Vazquez-Rodriguez, Lourdes Santana, et al.
International Journal of Biological Macromolecules|June 24, 2020
Looking for new xanthine oxidase inhibitors: 3-Phenylcoumarins versus 2-phenylbenzofuransBenedetta Era, Giovanna L Delogu, Francesca Pintus, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2016
2-Phenylbenzofuran derivatives as butyrylcholinesterase inhibitors: Synthesis, biological activity and molecular modelingGiovanna L Delogu, Maria J Matos, Maura Fanti, et al.
Journal of Biomolecular Structure & Dynamics|January 31, 2023
In silico approaches to develop new phenyl-pyrimidines as glycogen synthase kinase 3 (GSK-3) inhibitors with halogen-bonding capabilities: 3D-QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studiesDavid Cabezas, Guido Mellado, Nicolás Espinoza, et al.
Pageof 5